{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:27:51Z","timestamp":1787840871648,"version":"build-2784847793"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.4103\/idoj.idoj_534_23","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T08:00:25Z","timestamp":1716278425000},"page":"685-686","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Vildagliptin-Induced Tongue Angioedema: An Uncommon Occurrence"],"prefix":"10.4103","volume":"15","author":[{"given":"Shreya","family":"Poddar","sequence":"first","affiliation":[{"name":"Department of Dermatology, Asansol District Hospital, Asansol, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somodyuti","family":"Chandra","sequence":"additional","affiliation":[{"name":"Consultant Dermatologist, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrashis","family":"Podder","sequence":"additional","affiliation":[{"name":"Department of Dermatology, College of Medicine and Sagore Dutta Hospital, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,20]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2332\/allergolint.12-RAI-0493","article-title":"Recent advances in drug-induced angioedema","volume":"61","author":"Inomata","year":"2012","journal-title":"Allergol Int"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","article-title":"Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema","volume":"54","author":"Brown","year":"2009","journal-title":"Hypertension"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12948-021-00164-7","article-title":"Angioedema associated with dipeptidyl peptidase-IV inhibitors","volume":"19","author":"Cassano","year":"2021","journal-title":"Clin Mol Allergy"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-021-08841-w","article-title":"Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema","volume":"61","author":"Maurer","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11906-018-0859-x","article-title":"ACE Inhibitor-induced angioedema:A review","volume":"20","author":"Kostis","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2332\/allergolint.12-RAI-0493","article-title":"Recent advances in drug-induced angioedema","volume":"61","author":"Inomata","year":"2012","journal-title":"Allergol Int"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1573399813666170214113856","article-title":"Dipeptidyl peptidase-4 inhibitor induced angioedema-An overlooked adverse drug reaction?","volume":"14","author":"Scott","year":"2018","journal-title":"Curr Diabetes Rev"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"23247096211033049","DOI":"10.1177\/23247096211033049","article-title":"DPP-IV inhibitor-associated angioedema in patient with known history of ACE inhibitor angioedema","volume":"9","author":"Ejikeme","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"142","DOI":"10.7326\/L16-0649","article-title":"Sitagliptin and angioedema","volume":"167","author":"Arcani","year":"2017","journal-title":"Ann Intern Med"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6823-10-7","article-title":"Safety and tolerability of sitagliptin in clinical studies:A pooled analysis of data from 10,246 patients with type 2 diabetes","volume":"10","author":"Williams-Herman","year":"2010","journal-title":"BMC Endocr Disord"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0970-2113.80343","article-title":"Adverse drug reaction and causality assessment scales","volume":"28","author":"Zaki","year":"2011","journal-title":"Lung India"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_534_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:31:04Z","timestamp":1787837464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_534_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_534_23","relation":{},"ISSN":["2229-5178","2249-5673"],"issn-type":[{"value":"2229-5178","type":"print"},{"value":"2249-5673","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,20]]},"assertion":[{"value":"2023-07-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}